Images
Participants
Contact
El Punt Avui, La Razón, El Periódico, El Economista, among other media, have published an article about the research that was financed with the 12 million euros collected in TV3’s 2012 Marató (telethon) dedicated to cancer. La Marató has highlighted, among others, two IRB Barcelona projects that were awarded funding. On the one hand, Núria López-Bigas developed the "Cancer Genome Interpreter", a platform that allows better selection of treatments for cancer and the prediction of patient response. And on the other, Salvador Aznar Benitah led a project addressing metastasis and its relation to the consumption of dietary fat.
Link to El Periódico
Link to El Economista
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
